Gary L. Wenk

发表

Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats

S. L. Mobley, R. Wiley, J. Stoehr, 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.

G. Wenk, D. Woodruff-Pak, R. W. Vogel, 2001, Proceedings of the National Academy of Sciences of the United States of America.

The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition

W. Danysz, G. Wenk, B. Hauss-Wegrzyniak, 2000, Experimental Brain Research.

Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats

G. Wenk, B. Hauss-Wegrzyniak, B. Willard, 1999, Neuroscience.

The toxicity of tumor necrosis factor-α upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's disease

G. Wenk, S. Rosi, B. Hauss-Wegrzyniak, 2003, Neuroscience.

Acetyl-l-carnitine: Behavioral, electrophysiological, and neurochemical effects

C. Barnes, G. Wenk, A. Markowska, 1993, Neurobiology of Aging.

Animal Models of Alzheimer’s Disease

G. Wenk, Gary L. Wenk, 1992 .

MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis.

S. L. Mobley, W. Danysz, G. Wenk, 1995, European journal of pharmacology.

Basal forebrain lesions and memory: alterations in neurotensin, not acetylcholine, may cause amnesia.

D. Olton, G. Wenk, A. Markowska, 1989, Behavioral neuroscience.

Chronic Brain Inflammation Results in Cell Loss in the Entorhinal Cortex and Impaired LTP in Perforant Path-Granule Cell Synapses

B. Hauss-Wegrzyniak, M. Lynch, G. Wenk, 2002, Experimental Neurology.

APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer’s disease

D. Butterfield, G. Wenk, H. Abdul, 2004, Neuroscience Letters.

Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors

C. Barnes, J. Meltzer, G. Wenk, 2000, Neuroscience.

Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-alpha by constant, but not pulsed, estrogen replacement.

L. K. Marriott, G. Wenk, D. Dorsa, 2007, Endocrinology.

No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use.

W. Danysz, G. Wenk, G. Quack, 2000, Life sciences.

Phenomic Microglia Diversity as a Druggable Target in the Hippocampus in Neurodegenerative Diseases

M. Giovannini, D. Pellegrini-Giampietro, D. Lana, 2023, International journal of molecular sciences.

Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning.

D. Woodruff-Pak, R. W. Vogel, Gary L. Wenk, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Differential effects of selective immunotoxic lesions of medial septal cholinergic cells on spatial working and reference memory.

B. McNaughton, C. Barnes, G. Wenk, 1996, Behavioral neuroscience.

Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons.

G. Wenk, S. Fiorucci, A. Mencarelli, 2000, European journal of pharmacology.

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain

G. Wenk, Y. Marchalant, H. Brothers, 2009, Molecular Psychiatry.

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation

G. Wenk, S. Rosi, Y. Marchalant, 2007, Neuroscience.

Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism

G. Wenk, H. D’Angelo, S. C. Hopp, 2014, Neuroscience.

Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat

C. Barnes, P. Worley, A. Vazdarjanova, 2006, Neuroscience.

Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus

L. K. Marriott, G. Wenk, D. Dorsa, 2007, Endocrine.

Analysis of galanin and the galanin antagonist M40 on delayed non-matching-to-position performance in rats lesioned with the cholinergic immunotoxin 192 IgG-saporin.

J. Crawley, G. Wenk, M. P. McDonald, 1997, Behavioral neuroscience.

Symposium "recovery from Brain Damage: Behavioral and Neurochemical Approaches'' Animal Models of Alzheimer's Disease: Are They Valid and Useful?

G. Wenk, Gary L. Wenk, 2022 .

Long-term behavioral changes in rats following organophosphonate exposure

D. Olton, K. Raffaele, J. McDonough, 1987, Pharmacology Biochemistry and Behavior.

Galanin peptide levels in hippocampus and cortex of galanin-overexpressing transgenic mice evaluated for cognitive performance

J. Crawley, A. Holmes, L. K. Marriott, 2002, Neuropeptides.

Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation.

L. K. Marriott, G. Wenk, R. S. Benton, 2002, Behavioral neuroscience.

Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis

G. Norman, G. Wenk, A. Devries, 2009, Neurobiology of Disease.

Chemokine receptor 5 antagonist d-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease

C. Pert, G. Wenk, S. Rosi, 2005, Neuroscience.